Skip to content

13F-HR/A filed by Alpha Wave Global, LP

Alpha Wave Global, LP filed this 13F-HR/A for the quarter ended 2015-06-30, filed 2015-08-18, with 16 holding rows worth $1,315,256,000.

Accession
0001172661-15-001663
Filed
2015-08-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, amendment of type restatement, 16 entries on the cover page, a total value of $1,315,256,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,315,256,000 with VALUE read as thousands by filing date, 13F file number 028-15151. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHENIERE ENERGY INC COM NEW16411R208Stock3,033,414$210,094,000thousands by filing date
ALLERGAN PLCG0177J108SHS529,542$160,695,000thousands by filing date
LIBERTY INTERACTIVE CORP53071M880LBT VENT COM A3,772,000$148,126,000thousands by filing date
SPIRIT AEROSYSTEMS HLDGS INC848574109COM CL A2,066,331$113,876,000thousands by filing date
ALLEGION PLCG0176J109ORD SHS1,652,344$99,372,000thousands by filing date
Vale Sa91912E204COM17,481,000$88,279,000thousands by filing date
PANDORA MEDIA INC698354107COM4,670,900$72,586,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR2,021,000$68,916,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock537,713$64,456,000thousands by filing date
CDK GLOBAL INC12508E101COM1,004,262$54,210,000thousands by filing date
META PLATFORMS INC CL A30303M102COM598,000$51,287,000thousands by filing date
DELTA AIR LINES INC COM NEW247361702Stock1,212,000$49,789,000thousands by filing date
MASONITE INTERNATIONAL CORP575385109COMMON STOCK-FO608,000$42,627,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM163,700$39,514,000thousands by filing date
TEKMIRA PHARMACEUTICALS COR87911B209COM NEW2,618,000$31,049,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM1,000,000$20,380,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-15-001637 superseded2015-08-14acceptance time not in the bulk data set
13F-HR/A 0001172661-15-001663this filing2015-08-18acceptance time not in the bulk data set